UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: ' | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Z
Number of items: 257.

'

't Hoen, PA; van der Wees, CG; Aartsma-Rus, A; Turk, R; Goyenvalle, A; Danos, O; ... van Deutekom, JC; + view all (2006) Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy. Pharmacogenomics , 7 (3) 281 - 297. 10.2217/14622416.7.3.281.

A

Alonzi, R; Hoskin, P; (2006) Functional imaging in clinical oncology: Magnetic resonance imaging- and computerised tomography-based techniques. CLINICAL ONCOLOGY , 18 (7) 555 - 570.

Alsop, AE; Teschendorff, AE; Edwards, PAW; (2006) Distribution of breakpoints on chromosome 18 in breast, colorectal, and pancreatic carcinoma cell lines. CANCER GENET CYTOGEN , 164 (2) 97 - 109. 10.1016/j.cancergencyto.2005.09.011.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJU-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. MOL CANCER THER , 5 (6) 1602 - 1609. 10.1158/1535-7163.MCT-06-0018.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Austin, SK; Starke, RD; Purdy, G; Lawrie, AS; Machin, SJ; Mackie, IJ; (2006) High affinity autoantibodies to ADAMTS13 in the antiphospholipid syndrome. In: BLOOD. (pp. 424A - 424A). AMER SOC HEMATOLOGY

B

Bates, AW; (2006) Dr Kahn's museum: obscene anatomy in Victorian London. J ROY SOC MED , 99 (12) 618 - 624.

Bates, AW; (2006) The worm, the demon and the virgin: the medieval theories on extraordinary generation: a study on the relations between theology, natural philosophy and medicine. MED HIST , 50 (3) 410 - 411. Gold open access

Batten, P; Sarathchandra, P; Antoniw, JW; Tay, SS; Lowdell, MW; Taylor, PM; Yacoub, MH; (2006) Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves. TISSUE ENG , 12 (8) 2263 - 2273.

Beck, S; (2006) Epigenetics - The missing link between genetics, disease and the environment. TOXICOL LETT , 164 S18 - S19. 10.1016/j.toxlet.2006.06.042.

Bellodi, C; Kindle, K; Bernassola, F; Cossarizza, A; Dinsdale, D; Melino, G; ... Salomoni, P; + view all (2006) A cytoplasmic PML mutant inhibits p53 function. CELL CYCLE , 5 (22) 2688 - 2692.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; ... Salomoni, P; + view all (2006) Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-alpha. J BIOL CHEM , 281 (20) 14465 - 14473. 10.1074/jbc.M600457200. Gold open access

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; ... Salomoni, P; + view all (2006) Role of cytoplasmic forms of PML and PML-RAR alpha in the response to therapy. In: TOXICOLOGY. (pp. 48 - 49). ELSEVIER IRELAND LTD

Benyo, Z; Gille, A; Bennett, CL; Clausen, BE; Offermanns, S; (2006) Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. MOLECULAR PHARMACOLOGY , 70 (6) 1844 - 1849. 10.1124/mol.106.030833.

Beresford, M; Sanghera, B; Wong, WL; Makris, A; (2006) Imaging of primary breast cancer with F-18-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour. SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013 USA

Beresford, MJ; Burcombe, R; Ah-See, ML; Stott, D; Makris, A; (2006) Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. CLINICAL ONCOLOGY , 18 (6) 453 - 458.

Beresford, MJ; Padhani, AP; Taylor, NJ; Ah-See, M-L; Stirling, JJ; Makris, A; ... Collins, DJ; + view all (2006) Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI. Journal of Magnetic Resonance Imaging , 24 (6) 1316 - 1325. 10.1002/jmri.20768.

Betticher, DC; Martinelli, G; Radford, JA; Kaufmann, M; Dyer, MJS; Kaiser, U; ... Linch, DC; + view all (2006) Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL). ANN ONCOL , 17 (10) 1546 - 1552. 10.1093/annonc/mdl153.

Billottet, C; Grandage, VL; Gale, RE; Quattropani, A; Rommel, C; Vanhaesebroeck, B; Khwaja, A; (2006) A selective inhibitor of the p110 delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. ONCOGENE , 25 (50) 6648 - 6659. 10.1038/sj.onc.1209670.

Bloor, AJ; Mackinnon, S; (2006) Cerebral tuberculosis post stem cell transplant. Eur J Haematol , 77 (5) 456 - ?. 10.1111/j.1600-0609.2006.00718.x.

Boone, JJM; Hochhauser, D; Hartley, JA; (2006) Modulation of the repair of cisplatin-induced DNA interstrand crosslinks by trastuzumab. In: EJC SUPPL. (pp. 151 - 151). PERGAMON-ELSEVIER SCIENCE LTD

Bose, F; Fugazza, C; Casalgrandi, M; Capelli, A; Cunningham, JM; Zhao, Q; ... Ronchi, A; + view all (2006) Functional interaction of CP2 with GATA-1 in the regulation of dythroid promoters. MOL CELL BIOL , 26 (10) 3942 - 3954. 10.1128/MCB.26.10.3942-3954.2006.

Boshoff, C; (2006) The biology of cancer. NATURE , 444 (7119) 549 - 549. 10.1038/444549a.

Bourhis, J; Overgaard, J; Audry, H; Ang, KK; Saunders, M; Bernier, J; ... Pignon, JP; + view all (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. , 368 (9538) 843 - 854. 10.1016/S0140-6736(06)69121-6.

Brissault, B; Kichler, A; Leborgne, C; Danos, O; Cheradame, H; Gau, J; ... Guis, C; + view all (2006) Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block. Biomacromolecules , 7 (10) 2863 - 2870. 10.1021/bm060499a.

Brissault, B; Leborgne, C; Guis, C; Danos, O; Cheradame, H; Kichler, A; (2006) Linear topology confers in vivo gene transfer activity to polyethylenimines. Bioconjug Chem , 17 (3) 759 - 765. 10.1021/bc050287v.

Brooks, S; Daley, F; Johns, P; Brandner, S; Short, SC; (2006) Pescadillo and CYP1B1: Novel metabolic targets in glioma. In: RADIOTHERAPY AND ONCOLOGY. (pp. S72 - S73). ELSEVIER IRELAND LTD

Buchmueller, KL; Bailey, SL; Matthews, DA; Taherbhai, ZT; Register, JK; Davis, ZS; ... Lee, M; + view all (2006) Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm. BIOCHEMISTRY-US , 45 (45) 13551 - 13565. 10.1021/bi061245c.

Burckbuchler, V; Wintgens, V; Lecomte, S; Percot, A; Leborgne, C; Danos, O; ... Amiel, C; + view all (2006) DNA compaction into new DNA vectors based on cyclodextrin polymer: surface enhanced Raman spectroscopy characterization. Biopolymers , 81 (5) 360 - 370. 10.1002/bip.20428.

Butcher, LM; Kennedy, JK; Plomin, R; (2006) Generalist genes and cognitive neuroscience. Curr.Opin.Neurobiol. , 16 (2) 145 - 151. 10.1016/j.conb.2006.03.004.

C

Cannon, M; Cesarman, E; Boshoff, C; (2006) KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. BLOOD , 107 (1) 277 - 284. 10.1182/blood-2005-06-2350. Gold open access

Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrone, S; Agaoglu, L; ... Alberti, D; + view all (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. BLOOD , 107 (9) 3455 - 3462. 10.1182/blood-2005-08-3430.

Cardigan, R; Lawrie, A; Mackie, I; Williamson, L; (2006) Effect of overnight 4 degrees C storage of whole blood on von Willebrand factor: reply. TRANSFUSION , 46 (6) 1059 - 1060.

Carmo, M; Faria, TQ; Falk, H; Coroadinha, AS; Teixeira, M; Merten, OW; ... Cruz, PE; + view all (2006) Relationship between retroviral vector membrane and vector stability. J Gen Virol , 87 (Pt 5) 1349 - 1356. 10.1099/vir.0.81302-0.

Carnell, DM; Smith, RE; Daley, FM; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2006) An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance. International Journal of Radiation Oncology Biology Physics , 65 (1) 91 - 99.

Carr, AJF; Tamai, TK; Young, LC; Ferrer, V; Dekens, MP; Whitmore, D; (2006) Light reaches the very heart of the zebrafish clock. CHRONOBIOLOGY INTERNATIONAL , 23 (1-2) 91 - 100. 10.1080/07420520500464395.

Cerdan, C; Bendall, SC; Wang, L; Stewart, M; Werbowetski, T; Bhatia, M; (2006) Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. NATURE MEDICINE , 12 (10) 1113 - 1114. 10.1038/nm1006-1113.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) 7411 - 7420. 10.1038/sj.onc.1209727.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) 1669 - 1675. 10.1158/1535-7163.MCT-06-0033.

Chakraverty, R; Cote, D; Buchli, J; Cotter, P; Hsu, R; Zhao, GL; ... Sykes, M; + view all (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J EXP MED , 203 (8) 2021 - 2031. 10.1084/jem.20060376. Green open access
file

Chin, YS; Bullard, J; Bryant, L; Bownes, P; Ostler, P; Hoskin, PJ; (2006) High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. CLINICAL ONCOLOGY , 18 (7) 474 - 479.

Cholongitas, E; Quaglia, A; Dhillon, AP; Patch, D; Burroughs, AK; (2006) Length versus width in liver biopsies. J HEPATOL , 44 (4) 822 - 823. 10.1016/j.jhep.2005.12.023.

Cholongitas, E; Senzolo, M; Standish, R; Marelli, L; Quaglia, A; Patch, D; ... Burroughs, AK; + view all (2006) A systematic review of the quality of liver biopsy specimens. AM J CLIN PATHOL , 125 (5) 710 - 721. 10.1309/W3XCNT4HKFBN2G0B.

Chong, G; Bhatnagar, A; Cunningham, D; Cosgriff, TM; Harper, PG; Steward, W; ... Carmichael, J; + view all (2006) Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol , 17 (3) 437 - 442. 10.1093/annonc/mdj090.

Chow, E; Hoskin, P; van der Linden, Y; Bottomley, A; Velikova, G; (2006) Quality of life and symptom end points in palliative bone metastases trials. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Chow, E; Hoskin, PJ; Wu, J; Roos, D; van der Linden, Y; Hartsell, W; ... Pater, J; + view all (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Coakley, M; Reddy, K; Mackie, I; Mallett, S; (2006) Transfusion triggers in orthotopic liver transplantation: A comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J CARDIOTHOR VASC AN , 20 (4) 548 - 553. 10.1053/j.jvca.2006.01.016.

Collin, MP; Hart, DNJ; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; ... Dickinson, AM; + view all (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J EXP MED , 203 (1) 27 - 33. 10.1084/jem.20051787.

Cook, G; Clark, RE; Crawley, C; Mackinnon, S; Russell, N; Thomson, K; ... Marks, DI; + view all (2006) The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. BIOL BLOOD MARROW TR , 12 (3) 293 - 300. 10.1016/j.bbmt.2005.10.019.

Cooper, CS; Nicholson, AG; Foster, C; Dodson, A; Edwards, S; Fletcher, A; ... Cheng, SJ; + view all (2006) Nuclear overexpression of the E2F3 transcription factor in human lung cancer. LUNG CANCER , 54 (2) 155 - 162. 10.1016/j.lungcan.2006.07.005.

Corsini, E; Viviani, B; Birindelli, S; Gilardi, F; Torri, A; Codeca, I; ... Colosio, C; + view all (2006) Molecular mechanisms underlying mancozeb-induced inhibition of TNF-alpha production. TOXICOL APPL PHARM , 212 (2) 89 - 98. 10.1016/j.taap.2005.07.002.

Croisier, E; MRes, DE; Deprez, M; Goldring, K; Dexter, DT; Pearce, RKB; ... Roncaroli, F; + view all (2006) Comparative study of commercially available anti-alpha-synuclein antibodies. NEUROPATH APPL NEURO , 32 (3) 351 - 356. 10.1111/j.1365-2990.2006.00722.x.

Crowther, DC; Page, R; Chandraratna, D; Lomas, DA; (2006) A Drosophila model of Alzheimer's disease. Methods Enzymol , 412 234 - 255. 10.1016/S0076-6879(06)12015-7.

Cutillas, PR; Khwaja, A; Graupera, M; Pearce, W; Gharbi, S; Waterfield, M; Vanhaesebroeck, B; (2006) Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. P NATL ACAD SCI USA , 103 (24) 8959 - 8964. 10.1073/pnas.0602101103. Gold open access

D

Damelin, M; Ooi, SKT; Bestor, TH; (2006) Combing over heritable gene silencing. NAT STRUCT MOL BIOL , 13 (2) 100 - 101. 10.1038/nsmb0206-100.

Danos, O; Svinartchouk, F; (2006) Dialysis-assisted two-dimensional gel electrophoresis. Electrophoresis , 27 (17) 3475 - 3479. 10.1002/elps.200500036.

de Bakker, PIW; McVean, G; Sabeti, PC; Miretti, MM; Green, T; Marchini, J; ... Rioux, JD; + view all (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. NAT GENET , 38 (10) 1166 - 1172. 10.1038/ng1885.

de Bruin, EC; van de Velde, CJ; van de Pas, S; Nagtegaal, ID; van Krieken, JH; Gosens, MJ; ... Marijnen, CA; + view all (2006) Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res , 12 (21) 6432 - 6436. 10.1158/1078-0432.CCR-06-0231.

de Laat, B; Derksen, RHWM; Mackie, IJ; Roest, M; Schoormans, S; Woodhams, BJ; ... van Heerde, WL; + view all (2006) Annexin A5 polymorphism (-1C -> T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. ANN RHEUM DIS , 65 (11) 1468 - 1472. 10.1136/ard.2005.045237.

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Jarmulowicz, M; Cassoni, A; ... Mackinnon, S; + view all (2006) The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. BIOL BLOOD MARROW TR , 12 (1) 75 - 83. 10.1016/j.bbmt.2005.08.036.

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; ... Milligan, DW; + view all (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. BLOOD , 107 (4) 1724 - 1730. 10.1182/blood-2005-08-3372.

Duarte, RF; Pamphilon, D; Cornish, J; Shaw, BE; Samson, D; Craddock, C; ... Goldman, JM; + view all (2006) Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. BONE MARROW TRANSPL , 37 (10) 901 - 908. 10.1038/sj.bmt.1705365.

Dzwonek, A; Clapson, M; Withey, S; Bates, A; Novelli, V; (2006) Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy. The Pediatric Infectious Disease Journal , 25 (2) 183 - 184.

E

Eckhardt, F; Lewin, J; Cortese, R; Rakyan, VK; Attwood, J; Burger, M; ... Beck, S; + view all (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. NAT GENET , 38 (12) 1378 - 1385. 10.1038/ng1909.

F

Field, D; Wilson, G; van der Gast, C; (2006) How do we compare hundreds of bacterial genomes? Curr Opin Microbiol , 9 (5) 499 - 504.

Finnegan, DPJ; Kettle, P; Drake, M; Matthews, C; Alexander, HD; Popat, R; ... Morris, TCM; + view all (2006) Bortezomib is effective in primary plasma cell leukemia. LEUKEMIA LYMPHOMA , 47 (8) 1670 - 1673. 10.1080/10428190500520954.

Flores, LV; Staples, AM; Mackay, H; Howard, CM; Uthe, PB; Sexton, JS; ... Lee, M; + view all (2006) Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. CHEMBIOCHEM , 7 (11) 1722 - 1729. 10.1002/cbic.200600155.

Florijn, RJ; Loves, W; Wenniger-Prick, LJJMMD; Mannens, MMAM; Tijmes, N; Brooks, SP; ... Bergen, AAB; + view all (2006) New mutations in the NHS gene in Nance-Horan Syndrome families from the Netherlands. EUR J HUM GENET , 14 (9) 986 - 990. 10.1038/sj.ejhg.5201671.

Follows, GA; Dhami, P; Gottgens, B; Bruce, AW; Campbell, PJ; Dillon, SC; ... Green, AR; + view all (2006) Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites. GENOME RES , 16 (10) 1310 - 1319. 10.1101/gr.5373606.

Ford, HER; Yap, YS; Miles, DW; Makris, A; Hall, M; Miller, L; ... Johnston, SRD; + view all (2006) A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemotherapy and Pharmacology , 58 (6) 809 - 815.

Fox, J; Alabassi, A; Patkar, V; Rose, T; Black, E; (2006) An ontological approach to modelling tasks and goals. COMPUT BIOL MED , 36 (7-8) 837 - 856. 10.1016/j.compbiomed.2005.04.011.

Fukuuchi, A; Nagamura, Y; Yaguchi, H; Ohkura, N; Obara, T; Tsukada, T; (2006) A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol , 36 (11) 739 - 744. 10.1093/jjco/hyl089.

G

Garden, OJ; Rees, M; Poston, GJ; Mirza, D; Saunders, M; Ledermann, J; ... Parks, RW; + view all (2006) Guidelines for resection of colorectal cancer liver metastases. Gut , 55 Suppl 3 iii1 - iii8. 10.1136/gut.2006.098053.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J THROMB HAEMOST , 4 (12) 2724 - 2726.

Gardiner, C; Williams, K; Longair, I; Mackie, IJ; Machin, SJ; Cohen, H; (2006) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. BRIT J HAEMATOL , 132 (5) 598 - 603. 10.1111/j.1365-2141.2005.05899.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2006) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. CLIN LAB HAEMATOL , 28 (2) 122 - 125.

Grandage, VL; Everington, T; Linch, DC; Khwaja, A; (2006) Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. BRIT J HAEMATOL , 135 (3) 303 - 316. 10.1111/j.1365-2141.2006.06291.x.

Greaves, LC; Preston, SL; Tadrous, PJ; Taylor, RW; Barron, MJ; Oukrif, D; ... McDonald, SAC; + view all (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. P NATL ACAD SCI USA , 103 (3) 714 - 719. 10.1073/pnas.0505903103.

Greaves, LC; Taylor, RW; Barron, MJ; Turnbull, DM; Preston, SL; Leedham, SJ; ... Novelli, MR; + view all (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proceedings of the National Academy of Sciences of the United States of America , 103 (3) 714 - 719. 10.1073/pnas.0505903103.

Gross, DA; Chappert, P; Leboeuf, M; Monteilhet, V; Van Wittenberghe, L; Danos, O; Davoust, J; (2006) Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products. Blood , 108 (6) 1841 - 1848. 10.1182/blood-2006-02-011981.

Gupta, N; Saleem, A; Kotz, B; Osman, S; Aboagye, EO; Phillips, R; ... Price, PM; + view all (2006) Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients. CLINICAL CANCER RESEARCH , 12 (10) 3115 - 3123.

H

Hackshaw, A; (2006) Smoke gets in your eyes – well only until mid-2007. Significance , 3 (2) 63 - 65.

Hamaguchi, A; Suggitt, M; Howard, PW; Gregson, SJ; Kasprzyk, PG; Thurston, DE; Hartley, JA; (2006) DNA cross-linking and in vivo antitumour activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057 (DRG-16). In: EJC SUPPL. (pp. 96 - 96). PERGAMON-ELSEVIER SCIENCE LTD

Harish, S; Hughes, RJ; Saifuddin, A; Flanagan, AM; (2006) Image-guided percutaneous biopsy of intramedullary lytic bone lesions: utility of aspirated blood clots. EUR RADIOL , 16 (9) 2120 - 2125. 10.1007/s00330-005-0127-8.

Haworth, C; Butcher, LM; Carnell, S; Wardle, J; Plomin, R; (2006) Genetic continuity and change for body mass index in middle childhood. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS , 141B (7) 720 - 720.

Hayes, MJ; Kimata, Y; Wattam, SL; Lindon, C; Mao, G; Yamano, H; Fry, AM; (2006) Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C. Nat. Cell Biol. , 8 (6) 607 - 614.

Hegemann, S; Hajioff, D; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; ... Keilmann, A; + view all (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) 654 - 662.

Herdman, MT; Pett, MR; Roberts, I; Alazawi, WO; Teschendorff, AE; Zhang, XY; ... Coleman, N; + view all (2006) Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. Carcinogenesis , 27 (11) 2341 - 2353. 10.1093/carcin/bgl172.

Herdman, MT; Pett, MR; Roberts, I; Alazawi, WOF; Teschendorff, AE; Zhang, XY; ... Coleman, N; + view all (2006) Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. CARCINOGENESIS , 27 (11) 2341 - 2353. 10.1093/carcin/bg1172.

Hergovich, A; Lisztwan, J; Thoma, CR; Wirbelauer, C; Barry, RE; Krek, W; (2006) Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. MOL CELL BIOL , 26 (15) 5784 - 5796. 10.1128/MCB.00232-06.

Hergovich, A; Schmitz, D; Hemmings, BA; (2006) The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. BIOCHEM BIOPH RES CO , 345 (1) 50 - 58. 10.1016/j.bbrc.2006.03.244.

Hergovich, A; Stegert, MR; Schmitz, D; Hemmings, BA; (2006) NDR kinases regulate essential cell processes from yeast to humans. NAT REV MOL CELL BIO , 7 (4) 253 - 264. 10.1038/nrm1891.

Ho, E; Vassileva, V; Lim-Soo, P; Allen, C; Piquette-Miller, M; (2006) Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. In: CLINICAL PHARMACOLOGY & THERAPEUTICS. (pp. P11 - P11). MOSBY, INC

Horton, R; Coggill, P; Miretti, MM; Sambrook, JG; Traherne, JA; Ward, R; ... Beck, S; + view all (2006) The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies. TISSUE ANTIGENS , 68 (5) 450 - 452. 10.1111/j.1399-0039.2006.00697.x.

Howard, PW; Chen, Z; Gregson, SJ; Stephenson, M; Klee, S; Hartley, JM; ... Thurston, DE; + view all (2006) The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1-c][1,4]benzodiazepine dimers. EJC SUPPL , 4 (12) 95 - 95.

Howard, PW; Tiberghien, A; Gregson, SJ; Kang, GD; Stephenson, M; Kiakos, K; ... Thurston, DE; + view all (2006) Design, synthesis and evaluation of extended heterocycle linked C81C8 ' pyrrolo[2,1-c][1,4]benzodiazepine DNA cross-linking agents. In: EJC SUPPL. (pp. 93 - 93). PERGAMON-ELSEVIER SCIENCE LTD

Hughes, DA; (2006) The use of scoring systems in patients with haematological malignancy. ACTA PAEDIATRICA , 95 47 - 51. 10.1080/08035320600618866.

Hughes, R; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; ... Novell, JR; + view all (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? International Journal of Colorectal Disease , 21 (1) 11 - 17.

I

Ings, SJ; Balsa, C; Leverett, D; Mackinnon, S; Linch, DC; Watts, MJ; (2006) Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. BRIT J HAEMATOL , 134 (5) 517 - 525. 10.1111/j.1365-2141.2006.06223.x.

J

Jagsi, R; Makris, A; Goldberg, S; Taghian, A; (2006) Intra-European differences in the radiotherapeutic management of breast cancer: A survey study. CLINICAL ONCOLOGY , 18 (5) 369 - 375.

Jennings, BH; Pickles, LM; Wainwright, SM; Roe, SM; Pearl, LH; Ish-Horowicz, D; (2006) Molecular recognition of transcriptional repressor motifs by the WD domain of the Groucho/TLE corepressor. Mol Cell , 22 (5) 645 - 655. 10.1016/j.molcel.2006.04.024.

Juergens, C; Weston, C; Lewis, I; Whelan, J; Paulussen, M; Oberlin, O; ... Craft, A; + view all (2006) Safety Assessment of Intensive Induction With Vincristine, Ifosfamide, Doxorubicin, and Etoposide (VIDE) in the Treatment of Ewing Tumors in the EURO-E.W.I.N.G. 99 Clinical Trial. Pediatric Blood and Cancer , 47 (1) 22 - 29.

K

Karavolos, S; Caplin, M; Benjamin, E; Crow, J; Mould, T; (2006) Primary mucinous carcinoid tumour of the ovary: a case report. EUR J GYNAECOL ONCOL , 27 (6) 618 - 620.

Khanduri, S; Gerrard, G; Barton, R; Mulvenna, P; Lee, SM; (2006) Clinical Trials assessing the optimal management of brain metastases-the state of play. Clinical Oncology , 18 (10) 744 - 746.

Khwaja, A; (2006) The role of Janus kinases in haemopoiesis and haematological malignancy. BRIT J HAEMATOL , 134 (4) 366 - 384. 10.1111/j.1365-2141.2006.06206.x.

Kimata, Y; Yamano, H; (2006) Structural analysis sheds light on APC/C-mediated ubiquitylation. Dev. Cell , 10 (1) 4 - 5.

Kinghorn, KJ; Crowther, DC; Sharp, LK; Nerelius, C; Davis, RL; Chang, HT; ... Lomas, DA; + view all (2006) Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease. J Biol Chem , 281 (39) 29268 - 29277. 10.1074/jbc.M600690200. Gold open access

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; ... Sunder-Plassmann, G; + view all (2006) Prevalence of uncontrolled hypertension in patients with Fabry disease. American Journal of Hypertension , 19 (8) 782 - 787.

Klupsch, K; Downward, J; (2006) The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. CELL DEATH DIFFER , 13 (12) 2157 - 2159. 10.1038/sj.cdd.4401955.

Kluza, J; Mazinghien, R; Irwin, H; Hartley, JA; Bailly, C; (2006) Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. ANTI-CANCER DRUG , 17 (2) 155 - 164.

Kocjan, G; (2006) What is the role of fine needle aspiration cytology in the multidisciplinary approach to breast carcinoma. In: Drinkovic, I, (ed.) Proceedings of the XIV World Congress on Breast Diseases. (pp. 105 - 108). MEDIMOND S R L

Kocjan, G; (2006) Fine Needle aspiration Cytology; Diagnostic Principles and Dilemmas. (Vol.1). (1 vols). (1 ed.). Springer -Verlag Berlin Heidelberg: Germany.

Kocjan, G; Feichter, G; Hagmar, B; Kapila, K; Kardum-Skelin, I; Kloboves, V; ... Herbert, A; + view all (2006) Fine needle aspiration cytology: a survey of current European practice. CYTOPATHOLOGY , 17 (5) 219 - 226.

Korman, AJ; Peggs, KS; Allison, JP; (2006) Checkpoint blockade in cancer immunotherapy. ADV IMMUNOL , 90 297 - 339. 10.1016/S0065-2776(06)90008-X.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; ... Harris, AL; + view all (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) 727 - 735. 10.1200/JCO.2005.02.7474.

Kyriakou, CA; Yong, KL; Benjamin, R; Pizzey, A; Dogan, A; Singh, N; ... Nathwani, AC; + view all (2006) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. J GENE MED , 8 (3) 253 - 264. 10.1002/jgm.840.

L

Lagging, M; Romero, AI; Westin, J; Norkrans, G; Dhillon, AP; Pawlotsky, JM; ... DITTO-HCV Study Grp,; + view all (2006) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. HEPATOLOGY , 44 (6) 1617 - 1625. 10.1002/hep.21407.

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. UNSPECIFIED

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. THORAX , 61 (1) 91 - 91. 10.1136/thx.2005.052233.

Lambros, MB; Simpson, PT; Jones, C; Natrajan, R; Westbury, C; Steele, D; ... Reis-Filho, JS; + view all (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest , 86 (4) 398 - 408. 10.1038/labinvest.3700390.

Laun, K; Coggill, P; Palmer, S; Sims, S; Ning, ZM; Ragoussis, J; ... Volz, A; + view all (2006) The leukocyte receptor complex in chicken is characterized by massive expansion and diversification of immunoglobulin-like loci. PLoS Genetics , 2 (5) , Article e73. 10.1371/journal.pgen.0020073. Green and gold open access
file

Lawrie, AS; Cardigan, R; Williamson, LW; Machin, SJ; Mackie, IJ; (2006) Fresh-frozen plasma (FFP) quality assessed by dynamics of the clotting process. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 118 - 119). BLACKWELL PUBLISHING

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; ... Hartley, JA; + view all (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. BIOORG MED CHEM LETT , 16 (24) 6161 - 6164. 10.1016/j.bmcl.2006.09.043.

Le Sann, C; Baron, A; Mann, J; van den Berg, H; Gunaratnam, M; Neidle, S; (2006) New mustard-linked 2-aryl-bis-benzimidazoles with anti-proliferative activity. Org Biomol Chem , 4 (7) 1305 - 1312. 10.1039/b600567e.

Ledermann, JA; Raja, F; (2006) Management strategies for partially platinum-sensitive ovarian cancer. American Journal of Cancer , 5 (5) 341 - 354. 10.2165/00024669-200605050-00005.

Lee, SM; (2006) Is EGFR expression important in non-small cell lung cancer? Thorax , 61 (2) 98 - 99.

Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; ... Young, RA; + view all (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell , 125 (2) 301 - 313. 10.1016/j.cell.2006.02.043.

Lehmann, DJ; Barnardo, MCNM; Fuggle, S; Quiroga, I; Sutherland, A; Warden, DR; ... Smith, AD; + view all (2006) Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J NEUROINFLAMM , 3 , Article 33. 10.1186/1742-2094-3-33. Green and gold open access
file

Lidove, O; Ramaswami, U; Jaussaud, R; Barbey, F; Maisonobe, T; Caillaud, C; ... Mehta, AFOSEI; + view all (2006) Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. International Journal of Clinical Practice , 60 (9) 1053 - 1059.

Lieb, JD; Beck, S; Bulyk, ML; Farnham, P; Hattori, N; Henikoff, S; ... Greally, JM; + view all (2006) Applying whole-genome studies of epigenetic regulation to study human disease. CYTOGENET GENOME RES , 114 (1) 1 - 15. 10.1159/000091922.

Lomas, DA; (2006) Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease. Proc Am Thorac Soc , 3 (6) 499 - 501. 10.1513/pats.200603-069MS. Gold open access

Lomas, DA; (2006) The selective advantage of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med , 173 (10) 1072 - 1077. 10.1164/rccm.200511-1797PP.

Lopez, M; Aguilera, R; Perez, C; Mendoza-Naranjo, A; Pereda, C; Ramirez, M; ... Salazar-Onfray, F; + view all (2006) The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines. IMMUNOBIOLOGY , 211 (1-2) 127 - 136. 10.1016/j.imbio.2005.11.003.

Lowdell, MW; Bakhsh, I; North, J; Marden, C; Addison, E; Mackinnon, S; (2006) Tumor-activated human NK cells specificall ylyse autologous and allogeneic NK-resistant tumor targets. In: BLOOD. (pp. 1059A - 1059A). AMER SOC HEMATOLOGY

M

MacGregor, EA; Frith, A; Ellis, J; Aspinall, L; Hackshaw, A; (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology , 67 (12) 2154 - 2158.

MacGregor, EA; Frith, A; Ellis, J; Aspinall, L; Hackshaw, A; (2006) Prevention of menstrual attacks of migraine - A double-blind placebo-controlled crossover study. Neurology , 67 (12) 2159 - 2163.

Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; ... Joel, SP; + view all (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: BLOOD. (pp. 735A - 735A). AMER SOC HEMATOLOGY

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. LEUKEMIA , 20 (3) 537 - 539. 10.1038/sj.leu.2404101.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia , 20 (3) 537 - 539.

Mantovani, J; Holic, N; Martinez, K; Danos, O; Perea, J; (2006) A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Res , 34 (19) e134 - ?. 10.1093/nar/gkl716.

Markusen, JF; Mason, C; Hull, DA; Town, MA; Tabor, AB; Clements, M; ... Dunnill, P; + view all (2006) Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. TISSUE ENG , 12 (4) 821 - 830.

Marquis, J; Paillard, L; Audic, Y; Cosson, B; Danos, O; Le Bec, C; Osborne, HB; (2006) CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J , 400 (2) 291 - 301. 10.1042/BJ20060490.

Mason, AJ; Martinez, A; Glaubitz, C; Danos, O; Kichler, A; Bechinger, B; (2006) The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J , 20 (2) 320 - 322. 10.1096/fj.05-4293fje.

Masterson, LA; Spanswick, VJ; Hartley, JA; Begent, RH; Howard, PW; Thurston, DE; (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. BIOORG MED CHEM LETT , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; ... Begent, RHJ; + view all (2006) A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. CLIN CANCER RES , 12 (21) 6509 - 6516. 10.1158/1078-0432.CCR-06-0769.

McTiernan, A; Driver, D; Michelagnoli, MP; Kilby, AM; Whelan, JS; (2006) High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. ANN ONCOL , 17 (8) 1301 - 1305. 10.1093/annonc/mdl108.

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2006) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. PEDIATR BLOOD CANCER , 46 (3) 345 - 350. 10.1002/pbc.20562.

Meaburn, E; Butcher, LM; Schalkwyk, LC; Plomin, R; (2006) Genotyping pooled DNA using 100K SNP microarrays: a step towards genomewide association scans. Nucleic Acids Res. , 34 (4) e27 - ?. 10.1093/nar/gnj027.

Middleton, D; Meenagh, A; Marsh, SGE; (2006) A HLA-Cw*03 allele, Cw*0322Q with limited or no expression. Tissue Antigens , 67 343 - 345.

Miranda, E; Lomas, DA; (2006) Neuroserpin: a serpin to think about. Cell Mol Life Sci , 63 (6) 709 - 722. 10.1007/s00018-005-5077-4.

Moore, MJ; Schultes, CM; Cuesta, J; Cuenca, F; Gunaratnam, M; Tanious, FA; ... Neidle, S; + view all (2006) Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem , 49 (2) 582 - 599. 10.1021/jm050555a.

Moorhouse, AD; Santos, AM; Gunaratnam, M; Moore, M; Neidle, S; Moses, JE; (2006) Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc , 128 (50) 15972 - 15973. 10.1021/ja0661919.

Morsi, H; Yong, KL; Jewell, AP; (2006) Preferential survival of acute lymphoblastic leukemia cells at 33 degrees C is associated with up-regulation of bcl-2. LEUKEMIA LYMPHOMA , 47 (6) 1117 - 1122. 10.1080/10428190500404498.

Mudie, NY; Swerdlow, AJ; Higgins, CD; Smith, P; Qiao, ZK; Hancock, BW; ... Linch, DC; + view all (2006) Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study. J CLIN ONCOL , 24 (10) 1568 - 1574. 10.1200/JCO.2005.04.2200.

Murugaesu, N; Schmid, P; Dancey, G; Agarwal, R; Holden, L; McNeish, I; ... Seckl, MJ; + view all (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol , 24 (30) 4862 - 4866. 10.1200/JCO.2006.06.2489.

N

Nathwani, AC; Gray, JT; Ng, CYC; Zhou, JF; Spence, Y; Waddington, SN; ... Davidoff, AM; + view all (2006) Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. BLOOD , 107 (7) 2653 - 2661. 10.1182/blood-2005-10-4035. Gold open access

Nikitenko, LL; Blucher, N; Fox, SB; Bicknel, R; Smith, DM; Rees, MCP; (2006) Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms. J CELL SCI , 119 (5) 910 - 922. 10.1242/jcs.02783.

Nikitenko, LL; Cross, T; Campo, L; Turley, H; Leek, R; Manek, S; ... Rees, MCP; + view all (2006) Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: Endothelial phenotype and association with microvascular density. CLIN CANCER RES , 12 (19) 5648 - 5658. 10.1158/1078-0432.CCR-06-0852.

O

Oliver, AW; Paul, A; Boxall, KJ; Barrie, SE; Aherne, GW; Garrett, MD; ... Pearl, LH; + view all (2006) Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange. EMBO J , 25 (13) 3179 - 3190. 10.1038/sj.emboj.7601209.

Ozdag, H; Teschendorff, AE; Ahmed, AA; Hyland, SJ; Blenkiron, C; Bobrow, L; ... Caldas, C; + view all (2006) Differential expression of selected histone modifier genes in human solid cancers. BMC GENOMICS , 7 , Article 90. 10.1186/1471-2164-7-90. Green and gold open access
file

P

Palmieri, C; Dhillon, T; Thirlwell, C; Newsom-Davis, T; Young, AM; Nelson, M; ... Bower, M; + view all (2006) Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV MED , 7 (5) 291 - 293.

Pamphilon, D; Mackinnon, S; Nacheva, E; Russell, N; Wilson, K; Clay, M; ... Contreras, M; + view all (2006) The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors. Bone Marrow Transplant , 38 (10) 699 - 700. 10.1038/sj.bmt.1705508.

Pankhurst, T; Howie, AJ; Adu, D; Wallace, DMA; Lipkin, GW; (2006) Incidental neoplasms in renal biopsies. NEPHROLOGY DIALYSIS TRANSPLANTATION , 21 (1) 64 - 69. 10.1093/ndt/gfi149.

Panner, A; Nakamura, JL; Parsa, AT; Rodriguez-Viciana, P; Berger, MS; Stokoe, D; Pieper, RO; (2006) MTOR-independent translational control of the extrinsic cell death pathway by RalA. MOL CELL BIOL , 26 (20) 7345 - 7357. 10.1128/MCB.00126-06.

Patel, BD; Loo, WJ; Tasker, AD; Screaton, NJ; Burrows, NP; Silverman, EK; Lomas, DA; (2006) Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax , 61 (7) 568 - 571. 10.1136/thx.2005.053827.

Patel, BD; Welch, AA; Bingham, SA; Luben, RN; Day, NE; Khaw, KT; ... Wareham, NJ; + view all (2006) Dietary antioxidants and asthma in adults. Thorax , 61 (5) 388 - 393. 10.1136/thx.2004.024935.

Pawlec, G; Marsh, SGE; (2006) ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank. Cancer Immunology, Immunotherapy , 55 623 - 627.

Pedrazzoli, P; Ledermann, JA; Lotz, JP; Leyvraz, S; Aglietta, M; Rosti, G; ... European Grp Blood Marrow Transpla,; + view all (2006) High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults. ANN ONCOL , 17 (10) 1479 - 1488. 10.1093/annonc/mdl044.

Peggs, KS; (2006) Improving cellular therapies in Epstein-Barr virus-associated Hodgkin's lymphoma: shifting the equilibrium between effectors and regulators - Commentary on: Bollard et al. In vivo expansion of LMP 1-and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leuk Lymphoma 2006; 47 : 837-842. LEUKEMIA LYMPHOMA , 47 (5) 787 - 789. 10.1080/10428190600648630.

Peggs, KS; (2006) Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans. CYTOTHERAPY , 8 (5) 427 - 436. 10.1080/14653240600851938.

Peggs, KS; Quezada, SA; Korman, AJ; Allison, JP; (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. CURR OPIN IMMUNOL , 18 (2) 206 - 213. 10.1016/j.coi.2006.01.011.

Pfisterer, J; Ledermann, JA; (2006) Management of platinum-sensitive recurrent ovarian cancer. SEMIN ONCOL , 33 (2) S12 - S16. 10.1053/j.seminoncol.2006.03.012.

Pfisterer, J; Ledermann, JA; (2006) Management of Platinum-Sensitive Recurrent Ovarian Cancer. Seminars in Oncology , 33 (SUPPL. 6) 12 - 16. 10.1053/j.seminoncol.2006.03.012.

Pillay, OC; Te Fong, LFW; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; ... Hardiman, P; + view all (2006) The association between polycystic ovaries and endometrial cancer. HUM REPROD , 21 (4) 924 - 929. 10.1093/humrep/dei420.

Pillay, OC; Wong, LF; Fong, TE; Crow, JC; Benjamin, E; Mould, T; ... Hardiman, P; + view all (2006) A study of the relationship between polycystic ovary syndrome and endometrial cancer. BJOG-INT J OBSTET GY , 113 (7) 856 - 856.

Pinti, M; Salomoni, P; Cossarizza, A; (2006) Anti-HIV drugs and the mitochondria. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS , 1757 (5-6) 700 - 707. 10.1016/j.bbabio.2006.05.001.

Plummer, R; Vidal, L; Li, L; Shaw, H; Perrett, R; Shahidi, M; ... de Bono, J; + view all (2006) Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumours with mutated EGFR. EJC SUPPL , 4 (12) 173 - 174.

Pollard, S; Conti, L; Smith, A; (2006) Exploitation of adherent neural stem cells in basic and applied neurobiology. Regen Med , 1 (1) 111 - 118. 10.2217/17460751.1.1.111.

Pollard, SM; Conti, L; Sun, Y; Goffredo, D; Smith, A; (2006) Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex , 16 Suppl 1 i112 - i120. 10.1093/cercor/bhj167.

Pollard, SM; Parsons, MJ; Kamei, M; Kettleborough, RN; Thomas, KA; Pham, VN; ... Stemple, DL; + view all (2006) Essential and overlapping roles for laminin alpha chains in notochord and blood vessel formation. Dev Biol , 289 (1) 64 - 76. 10.1016/j.ydbio.2005.10.006.

Popat, R; Goff, L; Oakervee, H; Cavenagh, JD; Joel, SP; (2006) Schedule dependent effect of bortezomib and melphalan for multiple myeloma associated with changes in Mcl-1 expression. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 99 - 99). BLACKWELL PUBLISHING

Popat, R; Joel, S; Oakervee, H; Cavenagh, J; (2006) Bortezomib for multiple myeloma. Expert Opin Pharmacother , 7 (10) 1337 - 1346. 10.1517/14656566.7.10.1337.

Popat, R; Oakervee, H; Curry, N; Foot, N; Morris, C; Drake, M; ... Cavenagh, JD; + view all (2006) Low dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for untreated multiple myeloma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 99 - 99). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Odeh, L; Craddock, C; ... Cavenagh, JD; + view all (2006) Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 98 - 98). BLACKWELL PUBLISHING

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; ... Cavenagh, JD; + view all (2006) A phase I/II trial of bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma. In: BLOOD. (pp. 1011A - 1011A). AMER SOC HEMATOLOGY

Pors, K; Shnyder, SD; Teesdale-Spittle, PH; Hartley, JA; Zloh, M; Searcey, M; Patterson, LH; (2006) Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: Potential for development of tumor-selective N-oxides. J MED CHEM , 49 (24) 7013 - 7023. 10.1021/jm0608154.

Pritzker, KPH; Gay, S; Jimenez, SA; Ostergaard, K; Pelletier, J-P; Revell, PA; ... van den Berg, WB; + view all (2006) Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis and Cartilage , 14 (1) 13 - 29.

Purnell, B; Sato, A; O'Kelley, A; Price, C; Summerville, K; Hudson, S; ... Hartley, JA; + view all (2006) DNA interstrand crosslinking agents: Synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD). BIOORG MED CHEM LETT , 16 (21) 5677 - 5681. 10.1016/j.bmcl.2006.08.005.

Q

Quezada, SA; Peggs, KS; Curran, MA; Allison, JP; (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J CLIN INVEST , 116 (7) 1935 - 1945. 10.1172/JCI27745. Green open access
file

R

Rades, D; Stalpers, LJA; Schulte, R; Veninga, T; Basic, H; Engenhart-Cabilic, R; ... Hoskin, PJ; + view all (2006) Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. EUROPEAN JOURNAL OF CANCER , 42 (8) 1052 - 1056.

Rades, D; Stalpers, LJA; Veninga, T; Rudat, V; Schulte, R; Hoskin, PJ; (2006) Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. The Journal of Urology , 175 (2) 552 - 556.

Rades, D; Walz, J; Stalpers, LJA; Veninga, T; Schulte, R; Obralic, N; ... Schild, SE; + view all (2006) Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: Results of a retrospective multi-center study. EUROPEAN UROLOGY , 49 (5) 846 - 852.

Rakyan, VK; Beck, S; (2006) Epigenetic variation and inheritance in mammals. CURR OPIN GENET DEV , 16 (6) 573 - 577. 10.1016/j.gde.2006.09.002.

Ranson, M; Middleton, MR; Bridgewater, J; Lee, SM; Dawson, M; Jowle, D; ... Margison, GP; + view all (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res , 12 (5) 1577 - 1584. 10.1158/1078-0432.CCR-05-2198.

Reis-Filho, JS; Westbury, C; Pierga, JY; (2006) The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol , 59 (3) 225 - 231. 10.1136/jcp.2005.028324.

Renard, C; Hart, E; Sehra, H; Beasley, H; Coggill, P; Howe, K; ... Beck, S; + view all (2006) The genomic sequence and analysis of the swine major histocompatibility complex. GENOMICS , 88 (1) 96 - +. 10.1016/j.ygeno.2006.01.004.

Rivière, C; Danos, O; Douar, AM; (2006) Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther , 13 (17) 1300 - 1308. 10.1038/sj.gt.3302766.

Robertson, AS; Belorgey, D; Gubb, D; Dafforn, TR; Lomas, DA; (2006) Inhibitory activity of the Drosophila melanogaster serpin Necrotic is dependent on lysine residues in the D-helix. J Biol Chem , 281 (36) 26437 - 26443. 10.1074/jbc.M606085200. Gold open access

Robinson, J; Waller, MJ; Fail, S; Marsh, SGE; (2006) The IMGT/HLA and IPD Databases. Human Mutation , 27 (12) 1192 - 1199. 10.1002/humu.20406.

Rodriguez-Viciana, P; Collins, C; Fried, M; (2006) Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. P NATL ACAD SCI USA , 103 (51) 19290 - 19295. 10.1073/pnas.0609343103.

Rodriguez-Viciana, P; Collins, CH; Moule, MG; Fried, M; (2006) Chromosomal instability at a mutational hotspot in polyoma middle T-antigen affects its ability to activate the ARF-p53 tumor suppressor pathway. ONCOGENE , 25 (10) 1454 - 1462. 10.1038/sj.onc.1209197.

Rodriguez-Viciana, P; McCormick, F; (2006) Ras ubiquitination: Coupling spatial-sorting and signal transmission. CANCER CELL , 9 (4) 243 - 244. 10.1016/j.ccr.2006.03.025.

Rodriguez-Viciana, P; Oses-Prieto, J; Burlingame, A; Fried, M; McCormick, F; (2006) A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. MOL CELL , 22 (2) 217 - 230. 10.1016/j.molcel.2006.03.027.

Rodriguez-Viciana, P; Tetsu, O; Tidyman, WE; Estep, AL; Conger, BA; Cruz, MS; ... Rauen, KA; + view all (2006) Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. SCIENCE , 311 (5765) 1287 - 1290. 10.1126/science.1124642.

Romero, AI; Lagging, M; Westin, J; Dhillon, AP; Dustin, LB; Pawlotsky, JM; ... DITTO HCV Study Grp,; + view all (2006) Interferon (IFN)-gamma-inducible protein-10: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. JOURNAL OF INFECTIOUS DISEASES , 194 (7) 895 - 903.

Ronald, A; Happe, F; Bolton, P; Butcher, LM; Price, TS; Wheelwright, S; ... Plomin, R; + view all (2006) Genetic heterogeneity between the three components of the autism spectrum: a twin study. J.Am.Acad.Child Adolesc.Psychiatry , 45 (6) 691 - 699. 10.1097/01.chi.0000215325.13058.9d.

Roscioli, T; Cliffe, ST; Bloch, DB; Bell, CG; Mullan, G; Taylor, PJ; ... Buckley, MF; + view all (2006) Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet , 38 (6) 620 - 622. 10.1038/ng1780.

Rossi, C; Angelucci, A; Costantin, L; Braschi, C; Mazzantini, M; Babbini, F; ... Caleo, M; + view all (2006) Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. EUR J NEUROSCI , 24 (7) 1850 - 1856. 10.1111/j.1460-9568.2006.05059.x.

Rossi, M; Aqeilan, RI; Neale, M; Candi, E; Salomoni, P; Knight, RA; ... Melino, G; + view all (2006) The E3 ubiquitin ligase Itch controls the protein stability of p63. P NATL ACAD SCI USA , 103 (34) 12753 - 12758. 10.1073/pnas.0603449103.

Ruszniewski, P; Delle Fave, G; Cadiot, G; Komminoth, P; Chung, D; Kos-Kudla, B; ... Rindi, G; + view all (2006) Well-differentiated gastric tumors/carcinomas. NEUROENDOCRINOLOGY , 84 (3) 158 - 164. 10.1159/000098007.

S

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; ... Chester, KA; + view all (2006) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , 39 (1-3) 141 - 150. 10.1016/j.ijbiomac.2006.03.022.

Salomoni, P; Guernah, I; Pandolfi, PP; (2006) The PML-nuclear body associated protein Daxx regulates the cellular response to CD40. CELL DEATH DIFFER , 13 (4) 672 - 675. 10.1038/sj.cdd.4401820.

Salomoni, P; Khelifi, AF; (2006) Daxx: death or survival protein? TRENDS CELL BIOL , 16 (2) 97 - 104. 10.1016/j.tcb.2005.12.002.

Sambrook, JG; Sehra, H; Coggill, P; Humphray, S; Palmer, S; Sims, S; ... Beck, S; + view all (2006) Identification of a single killer immunoglobulin-like receptor (KIR) gene in the porcine leukocyte receptor complex on chromosome 6q. IMMUNOGENETICS , 58 (5-6) 481 - 486. 10.1007/s00251-006-0110-9.

Schreiber, J; Jenner, RG; Murray, HL; Gerber, GK; Gifford, DK; Young, RA; (2006) Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci U S A , 103 (15) 5899 - 5904. 10.1073/pnas.0510996103.

Schwarting, A; Dehout, F; Feriozzi, S; Beck, M; Mehta, A; Sunder-Plassmann, G; ... Hernández, S; + view all (2006) Enzyme replacement therapy and renal function in 201 patients with Fabry disease. Clinical Nephrology , 66 (2) 77 - 84.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, S; Cohen, H; (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. BLOOD COAGUL FIBRIN , 17 (6) 459 - 463.

Shah, JS; Hughes, D; Tayebjee, M; Macfadyen, R; Mehta, A; Elliott, PM; (2006) Extracellular matrix turnover and disease severity in Anderson-Fabry disease. In: ACTA PAEDIATR. (pp. 118 - 118). TAYLOR & FRANCIS AS

Sharp, LK; Mallya, M; Kinghorn, KJ; Wang, Z; Crowther, DC; Huntington, JA; ... Lomas, DA; + view all (2006) Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis. FEBS J , 273 (11) 2540 - 2552. 10.1111/j.1742-4658.2006.05262.x.

Shaw, BE; Marsh, SGE; Mayor, NP; Russell, NH; Madrigal, JA; (2006) HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. BLOOD , 107 (3) 1220 - 1226. 10.1182/blood-2005-08-3121.

Sieber, OM; Segditsas, S; Knudsen, AL; Zhang, J; Luz, J; Rowan, AJ; ... Tomlinson, IPM; + view all (2006) Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. GUT , 55 (10) 1440 - 1448. 10.1136/gut.2005.087106.

Silva, J; Chambers, I; Pollard, S; Smith, A; (2006) Nanog promotes transfer of pluripotency after cell fusion. Nature , 441 (7096) 997 - 1001. 10.1038/nature04914.

Soffietti, R; Cornu, P; Delattre, JY; Grant, R; Graus, F; Grisold, W; ... Vecht, C; + view all (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. EUROPEAN JOURNAL OF NEUROLOGY , 13 (7) 674 - 681.

Spiro, SG; James, LE; Rudd, RM; Trask, CW; Tobias, JS; Snee, M; ... Hackshaw, AK; + view all (2006) Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. JOURNAL OF CLINICAL ONCOLOGY , 24 (24) 3823 - 3830. 10.1200/JCO.2005.05.3181.

Stainsby, D; Jones, H; Asher, D; Atterbury, C; Boncinelli, A; Brant, L; ... Group, SS; + view all (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfusion medicine reviews , 20 273 - 282.

Starke, R; Mackie, I; Drummond, O; MacGregor, I; Harrison, P; Machin, S; (2006) Prion protein in patients with renal failure. TRANSFUSION MED , 16 (3) 165 - 168. 10.1111/j.1365-3148.2006.00662.x.

Steele, AJ; Jones, DT; Ganeshaguru, K; Duke, VM; Yogashangary, BC; North, JM; ... Wickremasinghe, RG; + view all (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. LEUKEMIA , 20 (6) 1073 - 1079. 10.1038/sj.leu.2404230.

Steele, AJ; Jones, DT; Ganeshaguru, K; Duke, VM; Yogashangary, BC; North, JM; ... Wickremasinghe, RG; + view all (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia , 20 (6) 1073 - 1079. 10.1038/sj.leu.2404230.

Stephens, R; Hoskin, P; (2006) Clinical trials and modern advertising: The Lung Cancer Trials Flowchart. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Stewart, MH; Bossé, M; Chadwick, K; Menendez, P; Bendall, SC; Bhatia, M; (2006) Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods , 3 (10) 807 - 815. 10.1038/nmeth939.

Streck, CJ; Dickson, PV; Ng, CYC; Zhou, J; Hall, MM; Davidoff, AM; ... Nathwani, AC; + view all (2006) Antitumor efficacy of AAV-mediated systemic delivery of interferon-β. Cancer Gene Therapy , 13 (1) 99 - 106. 10.1038/sj.cgt.7700878.

Szlosarek, PW; Fennell, DA; Rudd, RM; Lind, M; Ranson, M; Hackshaw, A; ... Steele, JPC; + view all (2006) A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma. In: LUNG CANCER. (pp. S54 - S54).

T

Teer, JK; Machida, YJ; Labit, H; Novac, O; Hyrien, O; Marheineke, K; ... Dutta, A; + view all (2006) Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation have a defect in p53 activation and Cdk2 kinase activation. J BIOL CHEM , 281 (10) 6253 - 6260. 10.1074/jbc.M507150200. Gold open access

Teschendorff, AE; Naderi, A; Barbosa-Morais, NL; Caldas, C; (2006) PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer. BIOINFORMATICS , 22 (18) 2269 - 2275. 10.1093/bioinformatics/btl174.

Teschendorff, AE; Naderi, A; Barbosa-Morais, NL; Pinder, SE; Ellis, IO; Aparicio, S; ... Caldas, C; + view all (2006) A consensus prognostic gene expression classifier for ER positive breast cancer. GENOME BIOL , 7 (10) , Article R101. 10.1186/gb-2006-7-10-r101.

Thomson, K; Julie, M; Pang, K; Samuel, E; Desborough, M; Lowdell, MW; Mackinnon, S; (2006) Direct isolation of donor-derived antigen - Specific T cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic transplantation. In: BLOOD. (pp. 177A - 178A). AMER SOC HEMATOLOGY

Thomson, KJ; Mackinnon, S; (2006) Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia. CURR OPIN HEMATOL , 13 (4) 273 - 279.

Tobar, JA; Carreno, LJ; Bueno, SM; Gonzalez, PA; Mora, JE; Quezada, SA; Kalergis, AM; (2006) Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. INFECT IMMUN , 74 (11) 6438 - 6448. 10.1128/IAI.00063-06.

Tolner, B; Smith, L; Begent, RHJ; Chester, KA; (2006) Expanded-bed adsorption immobilized-metal affinity chromatography. NAT PROTOC , 1 (3) 1213 - 1222. 10.1038/nprot.2006.127.

Tolner, B; Smith, L; Begent, RHJ; Chester, KA; (2006) Production of recombinant protein in Pichia pastoris by fermentation. NAT PROTOC , 1 (2) 1006 - 1021. 10.1038/nprot.2006.126.

Tomita, K; Cooper, JP; (2006) The meiotic chromosomal bouquet: SUN collects flowers. Cell , 125 (1) 19 - 21. 10.1016/j.cell.2006.03.020.

Traherne, JA; Horton, R; Roberts, AN; Miretti, M; Hurles, ME; Stewart, CA; ... Beck, S; + view all (2006) Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLOS GENET , 2 (1) , Article e9. 10.1371/journal.pgen.0020009. Green and gold open access
file

V

Venables, K; Miles, EA; Aird, EGA; Hoskin, PJ; (2006) What is the optimum breast plan: a study based on the START trial plans. British Journal of Radiology , 79 (945) 734 - 739.

Veron, P; Boutin, S; Bernard, J; Danos, O; Davoust, J; Masurier, C; (2006) Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med , 8 (8) 951 - 961. 10.1002/jgm.923.

Vig, S; Chitolie, A; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A; (2006) The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. BRIT J SURG , 93 (5) 577 - 581. 10.1002/bjs.5300.

Viviani, B; Gardoni, F; Bartesaghi, S; Corsini, E; Facchi, A; Galli, CL; ... Marinovich, M; + view all (2006) Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J BIOL CHEM , 281 (40) 30212 - 30222. 10.1074/jbc.M602156200. Gold open access

Vujovic, S; Henderson, S; Presneau, N; Odell, E; Jacques, TS; Tirabosco, R; ... Flanagan, AM; + view all (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J PATHOL , 209 (2) 157 - 165. 10.1002/path.1969.

W

Walter, PB; Fung, EB; Killilea, DW; Jiang, Q; Hudes, M; Madden, J; ... Harmatz, P; + view all (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. BRIT J HAEMATOL , 135 (2) 254 - 263. 10.1111/j.1365-2141.2006.06277.x.

Ward, KN; Leong, HN; Nacheva, EP; Howard, J; Atkinson, CE; Davies, NWS; ... Clark, DA; + view all (2006) Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. In: J CLIN MICROBIOL. (pp. 1571 - 1574). AMER SOC MICROBIOLOGY

Wells, G; Martin, CRH; Howard, PW; Sands, ZA; Laughton, CA; Tiberghien, A; ... Thurston, DE; + view all (2006) Design, synthesis, and biophysical and biological evaluation of a series of Pyrrolobenzodiazepine - Poly(N-methylpyrrole) conjugates. J MED CHEM , 49 (18) 5442 - 5461. 10.1021/jm051199z.

Westerman, M; Pizzey, A; Hirschman, J; Cerino, M; Well-Weiner, Y; Ramotar, P; ... Porter, J; + view all (2006) Plasma hemoglobin: Potential sources. In: BLOOD. (pp. 29B - 29B). AMER SOC HEMATOLOGY

Whelan, J; Seddon, B; Perisoglou, M; (2006) Management of osteosarcoma. Curr Treat Options Oncol , 7 (6) 444 - 455.

Wilkins, DK; Mayer, A; (2006) Development of antibodies for cancer therapy. EXPERT OPIN BIOL TH , 6 (8) 787 - 796. 10.1517/14712598.6.8.787.

Williams, RRE; Azuara, V; Perry, P; Sauer, S; Dvorkina, M; Jorgensen, H; ... Fisher, AG; + view all (2006) Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus. J CELL SCI , 119 (1) 132 - 140. 10.1242/jcs.02727.

Wilson, GD; Saunders, MI; Dische, S; Daley, FM; Buffa, FM; Richman, PI; Bentzen, SM; (2006) Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. EUROPEAN JOURNAL OF CANCER , 42 (3) 363 - 371.

Z

Zhang, B; McGee, B; Yamaoka, JS; Guglielmone, H; Downes, KA; Minoldo, S; ... Ginsburg, D; + view all (2006) Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. Blood , 107 (5) 1903 - 1907. 10.1182/blood-2005-09-3620.

Zhao, Y; Thomas, HD; Batey, MA; Cowell, IG; Richardson, CJ; Griffin, RJ; ... Curtin, NJ; + view all (2006) Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. CANCER RES , 66 (10) 5354 - 5362. 10.1158/0008-5472.CAN-05-4275.

This list was generated on Mon Dec 22 06:26:34 2014 GMT.